BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 28131952)

  • 1. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice.
    Truong QL; Cho Y; Park S; Park BK; Hahn TW
    Microb Pathog; 2016 Jun; 95():175-185. PubMed ID: 27057678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection.
    Zhang J; Yin S; Guo F; Meng R; Chen C; Zhang H; Li Z; Fu Q; Shi H; Hu S; Ni W; Li T; Zhang K
    J Microbiol; 2014 Aug; 52(8):681-8. PubMed ID: 24994009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
    Truong QL; Cho Y; Park S; Kim K; Hahn TW
    Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the transcriptional regulator GntR down regulated the expression of Genes Related to Virulence and Conferred Protection against Wild-Type Brucella Challenge in BALB/c Mice.
    Li ZQ; Zhang JL; Xi L; Yang GL; Wang SL; Zhang XG; Zhang JB; Zhang H
    Mol Immunol; 2017 Dec; 92():99-105. PubMed ID: 29055858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of BALB/c mice with Brucella abortus 2308ΔwbkA confers protection against wild-type infection.
    Li ZQ; Gui D; Sun ZH; Zhang JB; Zhang WZ; Zhang H; Guo F; Chen CF
    J Vet Sci; 2015; 16(4):467-73. PubMed ID: 26040616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB/c mice.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Han J; Zhang J
    Microb Pathog; 2017 Oct; 111():357-361. PubMed ID: 28916314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.
    Yang X; Clapp B; Thornburg T; Hoffman C; Pascual DW
    Vaccine; 2016 Oct; 34(44):5290-5297. PubMed ID: 27639282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
    Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.
    de Souza Filho JA; de Paulo Martins V; Campos PC; Alves-Silva J; Santos NV; de Oliveira FS; Menezes GB; Azevedo V; Cravero SL; Oliveira SC
    Infect Immun; 2015 Apr; 83(4):1458-64. PubMed ID: 25644010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
    Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
    Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.
    Willett JW; Herrou J; Czyz DM; Cheng JX; Crosson S
    Vaccine; 2016 Sep; 34(42):5073-5081. PubMed ID: 27591954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
    Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.